PAMORELIN

Welcome to the Brand page for “PAMORELIN”, which is offered here for Pharmaceutical preparations, chemiotherapeutical medicines and medicines that act on the endocrinal functions, hormones, and on metabolism for the treatment of prostate cancer, endometriosis, precocious puberty, breast cancer, in vitro fertilization, ovarian cancer, fibroma, and polycystic ovarian cancer;the wording pamorelin has no meaning in a foreign language.;.

Its status is currently believed to be active. Its class is unavailable. “PAMORELIN” is believed to be currently owned by “DEBIOPHARM S.A.”